Eleonora Pisa

828 total citations
27 papers, 509 citations indexed

About

Eleonora Pisa is a scholar working on Oncology, Epidemiology and Neurology. According to data from OpenAlex, Eleonora Pisa has authored 27 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 19 papers in Epidemiology and 13 papers in Neurology. Recurrent topics in Eleonora Pisa's work include Neuroendocrine Tumor Research Advances (19 papers), Lung Cancer Research Studies (18 papers) and Neuroblastoma Research and Treatments (13 papers). Eleonora Pisa is often cited by papers focused on Neuroendocrine Tumor Research Advances (19 papers), Lung Cancer Research Studies (18 papers) and Neuroblastoma Research and Treatments (13 papers). Eleonora Pisa collaborates with scholars based in Italy, United States and Switzerland. Eleonora Pisa's co-authors include Alfredo Santinelli, Daniela Stramazzotti, Guidalberto Fabris, Francesca Spada, Nicola Fazio, Massimo Barberis, Patrick Maisonneuve, Alessandro Vanoli, Fausto Sessa and Enrico Solcia and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Cancer and Annals of Surgical Oncology.

In The Last Decade

Eleonora Pisa

24 papers receiving 501 citations

Peers

Eleonora Pisa
P. Dominick Sanders United States
Eleonora Pisa
Citations per year, relative to Eleonora Pisa Eleonora Pisa (= 1×) peers P. Dominick Sanders

Countries citing papers authored by Eleonora Pisa

Since Specialization
Citations

This map shows the geographic impact of Eleonora Pisa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eleonora Pisa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eleonora Pisa more than expected).

Fields of papers citing papers by Eleonora Pisa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eleonora Pisa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eleonora Pisa. The network helps show where Eleonora Pisa may publish in the future.

Co-authorship network of co-authors of Eleonora Pisa

This figure shows the co-authorship network connecting the top 25 collaborators of Eleonora Pisa. A scholar is included among the top collaborators of Eleonora Pisa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eleonora Pisa. Eleonora Pisa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bertolaccini, Luca, Francesca Spada, Eleonora Pisa, et al.. (2025). Survival outcomes and prognostic factors in surgically resected lung carcinoids: A 25-year retrospective analysis. European Journal of Surgical Oncology. 51(10). 110366–110366.
2.
Bertolaccini, Luca, Francesca Spada, Eleonora Pisa, et al.. (2025). Impact of Surgical extent on survival in pulmonary typical carcinoids: a retrospective analysis. Updates in Surgery. 2 indexed citations
3.
Bertani, Emilio, Francesco Mattana, F. Collamati, et al.. (2024). Radio-Guided Surgery with a New-Generation β-Probe for Radiolabeled Somatostatin Analog, in Patients with Small Intestinal Neuroendocrine Tumors. Annals of Surgical Oncology. 31(7). 4189–4196. 3 indexed citations
4.
Bertani, Emilio, Francesco Mattana, F. Collamati, et al.. (2024). ASO Visual Abstract: Radio-Guided Surgery with a New-Generation β-Probe for Radio-Labeled Somatostatin Analog for Patients with Small-Intestinal Neuroendocrine Tumors. Annals of Surgical Oncology. 31(8). 5358–5359.
5.
Maisonneuve, Patrick, Alessandro Mangogna, Giovanni Centonze, et al.. (2021). Prognostic features of gastro‐entero‐pancreatic neuroendocrine neoplasms in primary and metastatic sites: Grade, mesenteric tumour deposits and emerging novelties. Journal of Neuroendocrinology. 33(8). e13000–e13000. 5 indexed citations
6.
Bertani, Emilio, F. Collamati, Marzia Colandrea, et al.. (2021). First Ex Vivo Results of β -Radioguided Surgery in Small Intestine Neuroendocrine Tumors with 90 Y-DOTATOC. Cancer Biotherapy and Radiopharmaceuticals. 36(5). 397–406. 7 indexed citations
7.
Colandrea, Marzia, Samuele Frassoni, Vincenzo Bagnardi, et al.. (2021). A Retrospective Analysis of the Correlation between Functional Imaging and Clinical Outcomes in Grade 3 Neuroendocrine Tumors (NETs G3). Diagnostics. 11(12). 2401–2401. 4 indexed citations
8.
Zerini, Dario, Francesca Spada, Nicola Fazio, et al.. (2020). Multidisciplinary team approach for Merkel cell carcinoma: the European Institute of Oncology experience with focus on radiotherapy. Tumori Journal. 107(2). 145–149. 5 indexed citations
9.
Lena, Marco Schiavo, Stefano Partelli, M. Paola Castelli, et al.. (2020). Histopathological and Immunophenotypic Changes of Pancreatic Neuroendocrine Tumors after Neoadjuvant Peptide Receptor Radionuclide Therapy (PRRT). Endocrine Pathology. 31(2). 119–131. 21 indexed citations
10.
Peri, Marta, Edoardo Botteri, Eleonora Pisa, et al.. (2018). A single-institution retrospective analysis of metachronous and synchronous metastatic bronchial neuroendocrine tumors. Journal of Thoracic Disease. 10(7). 3928–3939. 13 indexed citations
11.
Martins, Diana, Francesca Spada, Ioana Maria Lambrescu, et al.. (2017). Predictive Markers of Response to Everolimus and Sunitinib in Neuroendocrine Tumors. Targeted Oncology. 12(5). 611–622. 19 indexed citations
12.
Lambrescu, Ioana Maria, Simona Fica, Diana Martins, et al.. (2017). Metronomic and metronomic-like therapies in neuroendocrine tumors – Rationale and clinical perspectives. Cancer Treatment Reviews. 55. 46–56. 7 indexed citations
13.
Fazio, Nicola, Francesca Spada, Chiara Alessandra Cella, et al.. (2017). The role of multimodal treatment in patients with advanced lung neuroendocrine tumors. Journal of Thoracic Disease. 9(S15). S1501–S1510. 20 indexed citations
15.
Spada, Francesca, Lorenzo Antonuzzo, Riccardo Marconcini, et al.. (2016). Oxaliplatin-Based Chemotherapy in Advanced Neuroendocrine Tumors: Clinical Outcomes and Preliminary Correlation with Biological Factors. Neuroendocrinology. 103(6). 806–814. 59 indexed citations
16.
Milione, Massimo, Patrick Maisonneuve, Francesca Spada, et al.. (2016). The Clinicopathologic Heterogeneity of Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms: Morphological Differentiation and Proliferation Identify Different Prognostic Categories. Neuroendocrinology. 104(1). 85–93. 168 indexed citations
17.
Maffini, Fausto, Christopher A. French, Michael J. Cameron, et al.. (2013). A case of NUT midline carcinoma with no HPV infection, slight EWSR1rearrangement and strong expression of EGFR. Tumori Journal. 99(4). e152–e155. 4 indexed citations
18.
Maffini, Fausto, Anna Carla Bozzini, Chiara Casadio, et al.. (2012). Ovarian Serous Papillary Carcinoma, Metastatic to Intramammary Lymph-node Mimic a Primary Breast Carcinoma on RX Mammography. The Breast Journal. 18(5). 484–485. 5 indexed citations
19.
Galizia, Gennaro, Alfredo Santinelli, Cristian Loretelli, et al.. (2010). BRCA1 expression in triple negative sporadic breast cancers.. PubMed. 32(1). 24–9. 15 indexed citations
20.
Santinelli, Alfredo, Eleonora Pisa, Daniela Stramazzotti, & Guidalberto Fabris. (2007). HER‐2 status discrepancy between primary breast cancer and metastatic sites. Impact on target therapy. International Journal of Cancer. 122(5). 999–1004. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026